ArticleCurrent oncology (Toronto, Ont.)2008
Patient decision-making about complementary and alternative medicine in cancer management: context and process.
Article in Current oncology (Toronto, Ont.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- How parents choose to use CAM: a systematic review of theoretical models.BMC complementary and alternative medicine · 2009Pooled it
- Bridging the epistemic gap: a psychological acceptance model for the cross-cultural health communication of traditional Chinese medicine.Frontiers in public health · 2026Article
- Article
- Integrative and Complementary Health Practices for Chronic Pain: summary of clinical guideline recommendations.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2025Review
- Investigating the nature of open science practices across complementary, alternative, and integrative medicine journals: An audit.PloS one · 2024Article
- Terminally ill patients' and their relatives' experiences and behaviors regarding complementary and alternative medicine utilization in hospice palliative inpatient care units: a cross-sectional, multicenter survey.BMC complementary medicine and therapies · 2023Article
- Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway.BMC complementary medicine and therapies · 2022Article
- Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine.The EPMA journal · 2020Review
- Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018Article
- Cancer and Complementary Therapies: Current Trends in Survivors' Interest and Use.Integrative cancer therapies · 2018Article
- Understanding cancer survivors' information needs and information-seeking behaviors for complementary and alternative medicine from short- to long-term survival: a mixed-methods study.Journal of the Medical Library Association : JMLA · 2018Article
- The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2017Article
- Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.Plastic surgery (Oakville, Ont.) · 2017Review
- Social network bridging potential and the use of complementary and alternative medicine in later life.Social science & medicine (1982) · 2015Article
- Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure.Evidence-based complementary and alternative medicine : eCAM · 2015Article
- Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors.Journal of the advanced practitioner in oncology · 2013Review
- Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach.BMC complementary and alternative medicine · 2012Article
- Principles to guide integrative oncology and the development of an evidence base.Current oncology (Toronto, Ont.) · 2008Article
- Integrating complementary and alternative medicine into cancer care: Canadian oncology nurses' perspectives.Asia-Pacific journal of oncology nursingReview
- Integrative Oncology: International Perspectives.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIn this paper, we set out to describe the personal and social contexts of treatment decisions made by cancer patients concerning complementary and alternative medicine (CAM) and also the process through which cancer patients reach cam decisions throughout the cancer trajectory.
methodsWe selected and reviewed a variety of CAM decision-making models published in the past 10 years within the Canadian health literature.
resultsThe cam decision-making process is influenced by a variety of sociodemographic, disease-related, psychological, and social factors. We reviewed four main phases of the cam decision-making process: Taking stock of treatment options. Gathering and evaluating CAM information. Making CAM decisions. Revisiting the cam decision. Immediately following diagnosis, cancer patients become interested in taking stock of the full spectrum of conventional and CAM treatment options that may enhance the effectiveness of their treatment and mediate potential side effects. Information about CAM is then gathered from numerous information sources that vary in terms of credibility and scientific legitimacy, and is evaluated. When making a decision regarding CAM options, patients attempt to make sense of the diverse information obtained, while acknowledging their beliefs and values. The CAM decision is often revisited at key milestones, such as the end of conventional treatment and when additional information about disease, prognosis, and treatment is obtained.
conclusionsThe CAM decision-making process is a dynamic and iterative process that is influenced by a complex array of personal and social factors. Oncology health professionals need to be prepared to offer decision support related to CAM throughout the cancer trajectory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.